10012016Headline:

Atlanta, Georgia

HomeGeorgiaAtlanta

    Heading
    • Invokana and Farxiga Increase Warnings Over Acute Kidney Failure

      Invokana and Farxiga Increase Warnings Over Acute Kidney Failure

      The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been investigating for a long time now.   Check out our: Top 10 Things Invokana Patients […]

    • Kidney Failure and Kidney Disease Linked To Nexium, Prilosec and Prevacid

      Kidney Failure and Kidney Disease Linked To Nexium, Prilosec and Prevacid

      Nexium, Prilosec and Prevacid, commonly used to treat heartburn, indigestion, gastritis and/or acid reflux, have recently been linked to kidney disease and complications in two major independent medical studies. In one January 2016 medical study by the Journal of American […]

    • Canadian Invokana Lawsuit Seeks $1 Billion in Damages

      Canadian Invokana Lawsuit Seeks $1 Billion in Damages

      An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined […]

    • Concerns About Safety of Diabetes Drug Invokana Continue to be Raised

      Concerns About Safety of Diabetes Drug Invokana Continue to be Raised

      The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute […]

    • No Morcellation Adverse Events Brought to FDA’s Attention for Eight Years

      No Morcellation Adverse Events Brought to FDA’s Attention for Eight Years

      Although federal law requires the reporting of adverse events, no reports concerning power morcellators had been received by the U.S. Food and Drug Administration (FDA) prior to December 2013, according to The Cancer Letter. Prior to December 2013, the FDA […]

    • 40 Xarelto Bellwether Cases to be Selected, Says Judge

      40 Xarelto Bellwether Cases to be Selected, Says Judge

      According to a case management order issued by U.S. District Judge Eldon Fallon, 40 cases will be chosen for the Xarelto bellwether pool, with each side selecting 10 cases and an additional 20 chosen randomly. According to Judge Fallon’s plan: […]

    • Study Questions Actual Worth of IVC Filters for Trauma Patients

      Study Questions Actual Worth of IVC Filters for Trauma Patients

      A medical study published in the October 2015 issue of the Annals of Surgery takes a closer look at whether trauma patients actually benefit from having inferior vena cava (IVC) filters implanted, or instead face a greater risk of life-threatening […]

    • Most Americans Believe E-Cigarettes are Dangerous to Health, According to Poll

      Most Americans Believe E-Cigarettes are Dangerous to Health, According to Poll

      Electronic cigarettes (e-cigarettes) have only been around since 2004, too little time for researchers to complete definitive studies on their effects on human health, but Americans polled by STAT and the Harvard T.H. Chan School of Public Health believe that […]

    • Parties Select Xarelto Bellwether Cases, Litigation Moves Forward

      Parties Select Xarelto Bellwether Cases, Litigation Moves Forward

      The U.S. District Court in the Eastern District of Louisiana has started the process of selecting 40 cases for the bellwether trial pool. As required by an order dated December 17, 2015, the parties in the Xarelto multidistrict litigation (MDL) […]

    • Risperdal Claim Settled for $15.5M in Kentucky

      Risperdal Claim Settled for $15.5M in Kentucky

      Janssen Pharmaceuticals and its parent company, Johnson & Johnson, recently entered into a settlement agreement with the Commonwealth of Kentucky over allegations surrounding the drug Risperdal.  Janssen agreed to: Pay $15.5 million to the state of Kentucky Fully disclose the […]